For: | Nimer A, Mouch A. Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients. World J Gastroenterol 2012; 18(8): 800-805 [PMID: 22371640 DOI: 10.3748/wjg.v18.i8.800] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i8/800.htm |
Number | Citing Articles |
1 |
Chao-Nan Jin, Jing-Dan Chen, Ji-Fang Sheng. Vitamin D deficiency in hepatitis C virus infection: what is old? what is new?. European Journal of Gastroenterology & Hepatology 2018; 30(7): 741 doi: 10.1097/MEG.0000000000001134
|
2 |
Noemi Hernández-Alvarez, Juan Manuel Pascasio Acevedo, Enrique Quintero, Inmaculada Fernández Vázquez, María García-Eliz, Juan de la Revilla Negro, Javier Crespo García, Manuel Hernández-Guerra. Effect of season and sunlight on viral kinetics during hepatitis C virus therapy. BMJ Open Gastroenterology 2017; 4(1): e000115 doi: 10.1136/bmjgast-2016-000115
|
3 |
Yan Ren, Mei Liu, Jing Zhao, Feng Ren, Yu Chen, Jun-Feng Li, Jing-Yun Zhang, Feng Qu, Jin-Lan Zhang, Zhong-Ping Duan, Su-Jun Zheng. Serum vitamin D<sub>3</sub> does not correlate with liver fibrosis in chronic hepatitis C. World Journal of Gastroenterology 2015; 21(39): 11152-11159 doi: 10.3748/wjg.v21.i39.11152
|
4 |
Fang Yuan, Ning Wang, Yan Chen, Xinping Huang, Zhen Yang, Yingying Xu, Kai You, Jiaye Zhang, Guodong Wang, Yuanqi Zhuang, Tingcai Pan, Yue Xiong, Xiaorui Yu, Fan Yang, Yinxiong Li. Calcitriol promotes the maturation of hepatocyte-like cells derived from human pluripotent stem cells. The Journal of Steroid Biochemistry and Molecular Biology 2021; 211: 105881 doi: 10.1016/j.jsbmb.2021.105881
|
5 |
Mohamed El-Kassas, Abeer Awad. Metabolic aspects of hepatitis C virus. World Journal of Gastroenterology 2022; 28(22): 2429-2436 doi: 10.3748/wjg.v28.i22.2429
|
6 |
Livia Melo-Villar, Elisabeth Lampe, Adilson J. de Almeida, Leticia de P. Scalioni, Lia L. Lewis-Ximenez, Juliana C. Miguel, José A. Del Campo, Isidora Ranchal, Cristiane A. Villela-Nogueira, Manuel Romero-Gomez. Hypovitaminosis D and its relation to demographic and laboratory data among hepatitis C patients. Annals of Hepatology 2015; 14(4): 457 doi: 10.1016/S1665-2681(19)31166-4
|
7 |
Takuya Matsumura, Nao Sugiyama, Asako Murayama, Norie Yamada, Masaaki Shiina, Shinichi Asabe, Takaji Wakita, Michio Imawari, Takanobu Kato. Antimicrobial peptide LL‐37 attenuates infection of hepatitis C virus. Hepatology Research 2016; 46(9): 924 doi: 10.1111/hepr.12627
|
8 |
Stefan Pilz, Csilla Putz-Bankuti, Martin Gaksch, Walter Spindelboeck, Marius Haselberger, Florian Rainer, Andreas Posch, Philipp Kreuzer, Tatjana Stojakovic, Vanessa Stadlbauer, Barbara Obermayer-Pietsch, Rudolf Stauber. Effects of Vitamin D Supplementation on Serum 25-Hydroxyvitamin D Concentrations in Cirrhotic Patients: A Randomized Controlled Trial. Nutrients 2016; 8(5): 278 doi: 10.3390/nu8050278
|
9 |
Fatmanur Zehra Zelka, Rümeysa Rabia Kocatürk, Öznur Özge Özcan, Mesut Karahan. Can Nutritional Supports Beneficial in Other Viral Diseases Be Favorable for COVID-19?. Korean Journal of Family Medicine 2022; 43(1): 3 doi: 10.4082/kjfm.20.0134
|
10 |
Chao-Hung Hung, Tsung-Hui Hu, Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, Chuan-Mo Lee. Association of vitamin D receptor gene polymorphisms with response to peginterferon plus ribavirin in Asian patients with chronic hepatitis C. Journal of the Formosan Medical Association 2016; 115(4): 278 doi: 10.1016/j.jfma.2015.11.008
|
11 |
Mohamed Ahmed Khedr, Ahmad Mohamed Sira, Magdy Anwar Saber, Gamal Yousef Raia. Serum Adiponectin, Vitamin D, and Alpha-Fetoprotein in Children with Chronic Hepatitis C: Can They Predict Treatment Response?. International Journal of Hepatology 2015; 2015: 1 doi: 10.1155/2015/617623
|
12 |
Hasan Vosoghinia, Abbas Esmaeilzadeh, Azita Ganji, Seyed Mousal-Reza Hosseini, Saeid Amel Jamehdar, Maryam Salehi, Ali Bahari, Omid Ghanaei, Maryam Sahebari, Farnood Rajabzadeh, Kamran Ghaffarzadehgan, Ladan Goshayeshi. Vitamin D in Standard HCV Regimen (PEG-Interferon Plus Ribavirin), Its Effect on the Early Virologic Response Rate: A Clinical Trial. Razavi International Journal of Medicine 2016; 4(2) doi: 10.17795/rijm36632
|
13 |
M. Mrityunjaya, V. Pavithra, R. Neelam, P. Janhavi, P. M. Halami, P. V. Ravindra. Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.570122
|
14 |
Matthew T. Kitson, Gregory J. Dore, Jacob George, Peter Button, Geoffrey W. McCaughan, Darrell H.G. Crawford, William Sievert, Martin D. Weltman, Wendy S. Cheng, Stuart K. Roberts. Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. Journal of Hepatology 2013; 58(3): 467 doi: 10.1016/j.jhep.2012.11.017
|
15 |
Yasuteru Kondo, Takanobu Kato, Osamu Kimura, Tomoaki Iwata, Masashi Ninomiya, Eiji Kakazu, Masahito Miura, Takehiro Akahane, Yutaka Miyazaki, Tomoo Kobayashi, Motoyasu Ishii, Norihiro Kisara, Kumiko Sasaki, Haruo Nakayama, Takehiko Igarashi, Noriyuki Obara, Yoshiyuki Ueno, Tatsuki Morosawa, Tooru Shimosegawa, Makoto Makishima. 1(OH) Vitamin D3 Supplementation Improves the Sensitivity of the Immune-Response during Peg-IFN/RBV Therapy in Chronic Hepatitis C Patients-Case Controlled Trial. PLoS ONE 2013; 8(5): e63672 doi: 10.1371/journal.pone.0063672
|
16 |
Matthew T. Kitson, Stuart K. Roberts. D-livering the message: The importance of vitamin D status in chronic liver disease. Journal of Hepatology 2012; 57(4): 897 doi: 10.1016/j.jhep.2012.04.033
|
17 |
Andrea D. Branch, Burc Barin, Adeeb Rahman, Peter Stock, Thomas D. Schiano. Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: Multi-site study. Liver Transplantation 2014; 20(2): 156 doi: 10.1002/lt.23784
|
18 |
Mobeen Abdrabbo, Cole M. Birch, Michael Brandt, Kelsey A. Cicigoi, Stephen J. Coffey, Connor C. Dolan, Hannah Dvorak, Ava C. Gehrke, Audrey E. L. Gerzema, Abby Hansen, Ethan J. Henseler, Alyssa C. Huelsbeck, Ben LaBerge, Caterra M. Leavens, Christine N. Le, Allison C. Lindquist, Rickaela K. Ludwig, Jacob H. Reynolds, Nathaniel J. Severson, Brandon A. Sherman, Hunter W. Sillman, Michael A. Smith, Macey A. Smith, Marissa J. Snortheim, Levi M. Svaren, Emily C. Vanderpas, Miles J. Wackett, Alec J. Wozney, Sudeep Bhattacharyya, Sanchita Hati. Vitamin D and COVID‐19: A review on the role of vitamin D in preventing and reducing the severity of COVID‐19 infection. Protein Science 2021; 30(11): 2206 doi: 10.1002/pro.4190
|
19 |
Sirio Fiorino, Maddalena Zippi, Claudio Gallo, Debora Sifo, Sergio Sabbatani, Roberto Manfredi, Edoardo Rasciti, Leonardo Rasciti, Enrico Giampieri, Ivan Corazza, Paolo Leandri, Dario de Biase. The rationale for a multi-step therapeutic approach based on antivirals, drugs and nutrients with immunomodulatory activity in patients with coronavirus-SARS2-induced disease of different severities. British Journal of Nutrition 2021; 125(3): 275 doi: 10.1017/S0007114520002913
|
20 |
María Guzmán-Fulgencio, Mónica García-Álvarez, Juan Berenguer, Mª Ángeles Jiménez-Sousa, Jaime Cosín, Daniel Pineda-Tenor, Ana Carrero, Teresa Aldámiz, Emilio Álvarez, Juan Carlos López, Salvador Resino. Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients. Journal of Infection 2014; 68(2): 176 doi: 10.1016/j.jinf.2013.10.011
|
21 |
Rui Yu, Deming Tan, Qin Ning, Junqi Niu, Xuefan Bai, Shijun Chen, Jun Cheng, Yanyan Yu, Hao Wang, Min Xu, Guangfeng Shi, Mobin Wan, Xinyue Chen, Hong Tang, Jifang Sheng, Xiaoguang Dou, Junping Shi, Hong Ren, Maorong Wang, Hongfei Zhang, Zhiliang Gao, Chengwei Chen, Hong Ma, Jidong Jia, Jinlin Hou, Qing Xie, Jian Sun. Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B. Hepatology Research 2018; 48(3) doi: 10.1111/hepr.12972
|
22 |
En-Qiang Chen, Ying Shi, Hong Tang. New insight of vitamin D in chronic liver diseases. Hepatobiliary & Pancreatic Diseases International 2014; 13(6): 580 doi: 10.1016/S1499-3872(14)60295-2
|
23 |
Filippo Ansaldi, Andrea Orsi, Laura Sticchi, Bianca Bruzzone, Giancarlo Icardi. Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy. World Journal of Gastroenterology 2014; 20(29): 9633-9652 doi: 10.3748/wjg.v20.i29.9633
|
24 |
Meng-ping Wu, Jin-wei Zhang, Peng Huang, Ya-ping Han, Yun Zhang, Zhi-hang Peng, Jie Wang, Ping Zhu, Jing Su, Rong-bin Yu, Jun Li, Ming Yue. Genetic variations in vitamin D receptor were associated with the outcomes of hepatitis C virus infection among Chinese population. Journal of Human Genetics 2016; 61(2): 129 doi: 10.1038/jhg.2015.117
|
25 |
Amal Ahmed Mohamed, Eman R. Abd Almonaem, Amira I. Mansour, HebatAllah Fadel Algebaly, Rania Abdelmonem Khattab, Yasmine S. El Abd. Importance of studying the levels of hepcidin and vitamin D in Egyptian children with chronic hepatitis C. Journal of Translational Internal Medicine 2019; 7(1): 15 doi: 10.2478/jtim-2019-0004
|
26 |
Gamal Esmat, Maissa El Raziky, Aisha Elsharkawy, Dina Sabry, Mohamed Hassany, Amal Ahmed, Noha Assem, Mohamad El Kassas, Wahid Doss. Impact of Vitamin D Supplementation on Sustained Virological Response in Chronic Hepatitis C Genotype 4 Patients Treated by Pegylated Interferon/Ribavirin. Journal of Interferon & Cytokine Research 2015; 35(1): 49 doi: 10.1089/jir.2014.0060
|
27 |
Jean-Claude Souberbielle. Métabolisme et effets de la vitamine D, définition du déficit en vitamine D. Biologie Aujourd'hui 2014; 208(1): 55 doi: 10.1051/jbio/2014006
|
28 |
D. L. White, S. Tavakoli‐Tabasi, F. Kanwal, D. J. Ramsey, A. Hashmi, J. Kuzniarek, P. Patel, J. Francis, H. B. El‐Serag. The association between serological and dietary vitamin D levels and hepatitis C‐related liver disease risk differs in African American and white males. Alimentary Pharmacology & Therapeutics 2013; 38(1): 28 doi: 10.1111/apt.12341
|
29 |
Elżbieta Karczmarewicz, Edyta Czekuć-Kryśkiewicz, Paweł Płudowski. Effect of vitamin D status on pharmacological treatment efficiency. Dermato-Endocrinology 2013; 5(1): 1 doi: 10.4161/derm.25531
|
30 |
Francesco Petrillo, Arianna Petrillo, Francesca Paola Sasso, Antonietta Schettino, Angela Maione, Marilena Galdiero. Viral Infection and Antiviral Treatments in Ocular Pathologies. Microorganisms 2022; 10(11): 2224 doi: 10.3390/microorganisms10112224
|
31 |
Karan Sud, Akhil Parashar, Veeraish Chauhan. Textbook of Nephro-Endocrinology. 2018; : 373 doi: 10.1016/B978-0-12-803247-3.00021-0
|
32 |
Byoung‐Joon Song, Don C. Rockey. Status of research on vitamin D supplementation in treating or preventing liver fibrosis. Liver International 2013; 33(5): 653 doi: 10.1111/liv.12147
|
33 |
Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, Nicola Coppola, Guglielmo Borgia. GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infection. Expert Review of Anti-infective Therapy 2014; 12(10): 1179 doi: 10.1586/14787210.2014.945432
|
34 |
Adeeb H. Rahman, Andrea D. Branch. Vitamin D for your patients with chronic hepatitis C?. Journal of Hepatology 2013; 58(1): 184 doi: 10.1016/j.jhep.2012.07.026
|
35 |
Ioanna Aggeletopoulou, Konstantinos Thomopoulos, Athanasia Mouzaki, Christos Triantos. Vitamin D–VDR Novel Anti-Inflammatory Molecules—New Insights into Their Effects on Liver Diseases. International Journal of Molecular Sciences 2022; 23(15): 8465 doi: 10.3390/ijms23158465
|
36 |
Pankaj Puri. Will Vitamin D Supplementation Have a Role in the Treatment of Patients with Chronic Hepatitis C?. Journal of Clinical and Experimental Hepatology 2012; 2(4): 396 doi: 10.1016/j.jceh.2012.10.008
|
37 |
Tudor Lucian Pop, Claudia Sîrbe, Gabriel Benţa, Alexandra Mititelu, Alina Grama. The Role of Vitamin D and Vitamin D Binding Protein in Chronic Liver Diseases. International Journal of Molecular Sciences 2022; 23(18): 10705 doi: 10.3390/ijms231810705
|
38 |
H.‐B. Kim, S.‐K. Myung, Y.‐J. Lee, B.‐J. Park. Efficacy of vitamin D supplementation in combination with conventional antiviral therapy in patients with chronic hepatitis C infection: a meta‐analysis of randomised controlled trials. Journal of Human Nutrition and Dietetics 2018; 31(2): 168 doi: 10.1111/jhn.12503
|
39 |
Nghiem Xuan Hoan, Hoang Van Tong, Le Huu Song, Christian G Meyer, Thirumalaisamy P Velavan. Vitamin D deficiency and hepatitis viruses-associated liver diseases: A literature review. World Journal of Gastroenterology 2018; 24(4): 445-460 doi: 10.3748/wjg.v24.i4.445
|
40 |
Luiza Vitelo Andrighetto, Jacqueline Shaurich Dos Santos, Graziella Nicoletti, Patricia Martins Bock. INFLUÊNCIA DA VITAMINA D ASSOCIADA AO INTERFERON ALFA PEGUILADO E RIBAVIRINA NA RESPOSTA VIROLOGICA SUSTENTADA NA HEPATITE C CRÔNICA. Infarma - Ciências Farmacêuticas 2016; 28(3): 140 doi: 10.14450/2318-9312.v28.e3.a2016.pp140-148
|
41 |
Milica Bjelakovic, Dimitrinka Nikolova, Goran Bjelakovic, Christian Gluud. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database of Systematic Reviews 2021; 2021(10) doi: 10.1002/14651858.CD011564.pub3
|
42 |
Fabio Salvatore Macaluso, Marcello Maida, Maria Giovanna Minissale, Teresa Li Vigni, Simona Attardo, Emanuele Orlando, Salvatore Petta. Metabolic Factors and Chronic Hepatitis C: A Complex Interplay. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/564645
|
43 |
Mónica García-Álvarez, Daniel Pineda-Tenor, María A. Jiménez-Sousa, Amanda Fernández-Rodríguez, María Guzmán-Fulgencio, Salvador Resino. Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: A meta-analysis. Hepatology 2014; 60(5): 1541 doi: 10.1002/hep.27281
|
44 |
Ivan Gentile, Nicola Coppola, Antonio Riccardo Buonomo, Emanuela Zappulo, Guglielmo Borgia. Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus. Expert Opinion on Investigational Drugs 2014; 23(9): 1211 doi: 10.1517/13543784.2014.921680
|
45 |
Jean-Claude Souberbielle. Actualités sur la vitamine D. OCL 2014; 21(3): D304 doi: 10.1051/ocl/2013059
|
46 |
Edmondo Falleti, Sara Cmet, Carlo Fabris, Giovanna Fattovich, Annarosa Cussigh, Davide Bitetto, Elisa Ceriani, Ilaria Lenisa, Denis Dissegna, Donatella Ieluzzi, Anna Rostello, Mario Pirisi, Pierluigi Toniutto, Golo Ahlenstiel. Genetic Polymorphisms of Vitamin D Pathway Predict Antiviral Treatment Outcome in Slow Responder Naïve Patients with Chronic Hepatitis C. PLoS ONE 2013; 8(11): e80764 doi: 10.1371/journal.pone.0080764
|
47 |
Anindita Banerjee, Shreyasi Athalye, Naveen Khargekar, Poonam Shingade, Manisha Madkaikar. Chronic Hepatitis B and Related Liver Diseases Are Associated with Reduced 25-Hydroxy-Vitamin D Levels: A Systematic Review and Meta-Analysis. Biomedicines 2023; 11(1): 135 doi: 10.3390/biomedicines11010135
|
48 |
Gerald M. Higa, Jason Hicks, Christopher Isabella. Adjudication of the Alleged Role of Vitamin D in the Antimicrobial Pathway. Scientifica 2012; 2012: 1 doi: 10.6064/2012/129516
|
49 |
Ivan Gentile, Antonio Riccardo Buonomo, Federico Borgia, Giuseppe Castaldo, Guglielmo Borgia. Ledipasvir: a novel synthetic antiviral for the treatment of HCV infection. Expert Opinion on Investigational Drugs 2014; 23(4): 561 doi: 10.1517/13543784.2014.892581
|
50 |
M. O. El-Derany, N. M. Hamdy, N. L. Al-Ansari, H. O. El-Mesallamy. Integrative role of vitamin D related and Interleukin-28B genes polymorphism in predicting treatment outcomes of Chronic Hepatitis C. BMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0440-5
|
51 |
Jean-Claude Souberbielle, Gérard Maruani, Marie Courbebaisse. Vitamine D : métabolisme et évaluation des réserves. La Presse Médicale 2013; 42(10): 1343 doi: 10.1016/j.lpm.2013.07.010
|
52 |
Amiram Ravid, Noa Rapaport, Assaf Issachar, Arie Erman, Larisa Bachmetov, Ran Tur-Kaspa, Romy Zemel. 25-Hydroxyvitamin D Inhibits Hepatitis C Virus Production in Hepatocellular Carcinoma Cell Line by a Vitamin D Receptor-Independent Mechanism. International Journal of Molecular Sciences 2019; 20(9): 2367 doi: 10.3390/ijms20092367
|
53 |
John F. Arboleda, Silvio Urcuqui-Inchima. Vitamin D-Regulated MicroRNAs: Are They Protective Factors against Dengue Virus Infection?. Advances in Virology 2016; 2016: 1 doi: 10.1155/2016/1016840
|
54 |
Yoshie Omori‐Mizuno, Nobuaki Nakayama, Mie Inao, Junji Funyu, Shinichi Asabe, Kengo Tomita, Kou Nishikawa, Yasuo Hosoda, Masahiko Tanaka, Yoshiaki Hashimoto, Koji Yakabi, Yohei Koshima, Satoshi Mochida. Randomized study comparing vitamin D3 and 1α‐Hydroxyvitamin D3 in combination with pegylated interferon/ribavirin therapy for chronic hepatitis C. Journal of Gastroenterology and Hepatology 2015; 30(9): 1384 doi: 10.1111/jgh.12949
|
55 |
Yo-ichi Ishida, Masahiko Takeshita, Hiroaki Kataoka. Functional foods effective for hepatitis C: Identification of oligomeric proanthocyanidin and its action mechanism. World Journal of Hepatology 2014; 6(12): 870-879 doi: 10.4254/wjh.v6.i12.870
|
56 |
Goran Bjelakovic, Dimitrinka Nikolova, Marko Bjelakovic, Christian Gluud. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database of Systematic Reviews 2017; 2017(11) doi: 10.1002/14651858.CD011564.pub2
|
57 |
Monika Rau, Katharina Baur, Andreas Geier. Host Genetic Variants in the Pathogenesis of Hepatitis C. Viruses 2012; 4(12): 3281 doi: 10.3390/v4123281
|
58 |
Md. Tanvir Kabir, Md. Sahab Uddin, Md. Farhad Hossain, Jawaher A. Abdulhakim, Md. Asraful Alam, Ghulam Md Ashraf, Simona G. Bungau, May N. Bin-Jumah, Mohamed M. Abdel-Daim, Lotfi Aleya. nCOVID-19 Pandemic: From Molecular Pathogenesis to Potential Investigational Therapeutics. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00616
|
59 |
Satoe Yokoyama, Yoshiiku Kawakami, Michio Imamura, C Nelson Hayes, Hiroshi Kohno, Hirotaka Kohno, Keiji Tsuji, Yasuyuki Aisaka, Shinsuke Kira, Keitarou Yamashina, Michihiro Nonaka, Shoichi Takahashi, Takashi Moriya, Mikiya Kitamoto, Shiomi Aimitsu, Toshio Nakanishi, Hiroiku Kawakami, Kazuaki Chayama. Effect of prolonged administration of pegylated interferon/ribavirin therapy in genotypes 2a and 2b: Propensity score‐matched analysis. Journal of Gastroenterology and Hepatology 2015; 30(2): 337 doi: 10.1111/jgh.12706
|
60 |
Grace Lai-Hung Wong, Henry Lik-Yuen Chan, Hoi-Yun Chan, Chi-Hang Tse, Angel Mei-Ling Chim, Angeline Oi-Shan Lo, Vincent Wai-Sun Wong. Adverse Effects of Vitamin D Deficiency on Outcomes of Patients With Chronic Hepatitis B. Clinical Gastroenterology and Hepatology 2015; 13(4): 783 doi: 10.1016/j.cgh.2014.09.050
|
61 |
Mohamed E. Ali, Hamada M. Halby, Mamdouh Yones Ali, Elham Ahmed Hassan, Mohamed A. El-Mokhtar, Ibrahim M. Sayed, Marwa M. Thabet, Magdy Fouad, Ahmed M. El-Ashmawy, Zainab Gaber Mahran. Role of Serum Vitamin D, Interleukin 13, and microRNA-135a in Hepatocellular Carcinoma and Treatment Failure in Egyptian HCV-Infected Patients Receiving Direct Antiviral Agents. Viruses 2021; 13(10): 2008 doi: 10.3390/v13102008
|
62 |
Louise Berry, Will Irving. Predictors of hepatitis C treatment response: what's new?. Expert Review of Anti-infective Therapy 2014; 12(2): 183 doi: 10.1586/14787210.2014.874283
|
63 |
Asako Murayama, Hiroshi Saitoh, Akiko Takeuchi, Norie Yamada, Takuya Matsumura, Masaaki Shiina, Masamichi Muramatsu, Takaji Wakita, Michio Imawari, Takanobu Kato. Vitamin D derivatives inhibit hepatitis C virus production through the suppression of apolipoprotein. Antiviral Research 2018; 160: 55 doi: 10.1016/j.antiviral.2018.10.014
|
64 |
Olivier Bruyère, Etienne Cavalier, Jean-Claude Souberbielle, Heike A Bischoff-Ferrari, Charlotte Beaudart, Fanny Buckinx, Jean-Yves Reginster, René Rizzoli. Effects of vitamin D in the elderly population: current status and perspectives. Archives of Public Health 2014; 72(1) doi: 10.1186/2049-3258-72-32
|
65 |
Shahida Khan, Ashraf Ali, Sarah Khan, Ahmed Bakillah, Ghazi Damanhouri, Aziz Khan, Ahmed Makki, Ibtehal AlAnsari, Naheed Banu. Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D. Nutrition & Metabolism 2018; 15(1) doi: 10.1186/s12986-018-0251-5
|
66 |
Yuan‐Ping Han, Ming Kong, Sujun Zheng, Yan Ren, Longdon Zhu, Hongbo Shi, Zhongping Duan. Vitamin D in liver diseases: From mechanisms to clinical trials. Journal of Gastroenterology and Hepatology 2013; 28(S1): 49 doi: 10.1111/jgh.12016
|
67 |
Paula Iruzubieta, Álvaro Terán, Javier Crespo, Emilio Fábrega. Vitamin D deficiency in chronic liver disease. World Journal of Hepatology 2014; 6(12): 901-915 doi: 10.4254/wjh.v6.i12.901
|
68 |
Henry Lik-Yuen Chan, Magdy Elkhashab, Huy Trinh, Won Young Tak, Xiaoli Ma, Wan-Long Chuang, Yoon Jun Kim, Eduardo B. Martins, Lanjia Lin, Phillip Dinh, Prista Charuworn, Graham R. Foster, Patrick Marcellin. Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis B. Journal of Hepatology 2015; 63(5): 1086 doi: 10.1016/j.jhep.2015.06.025
|
69 |
Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, Guglielmo Borgia. Discontinued drugs in 2012 – 2013: hepatitis C virus infection. Expert Opinion on Investigational Drugs 2015; 24(2): 239 doi: 10.1517/13543784.2015.982274
|
70 |
Hans L Tillmann. Vitamins? The magic bullet against hepatitis C. Expert Review of Anti-infective Therapy 2012; 10(11): 1273 doi: 10.1586/eri.12.127
|
71 |
P.-O. Lang. La vitamine D : effets de son déficit et de sa supplémentation sur l’incidence des infections. NPG Neurologie - Psychiatrie - Gériatrie 2013; 13(74): 79 doi: 10.1016/j.npg.2012.11.003
|
72 |
Choongho Lee. Controversial Effects of Vitamin D and Related Genes on Viral Infections, Pathogenesis, and Treatment Outcomes. Nutrients 2020; 12(4): 962 doi: 10.3390/nu12040962
|
73 |
Miji Kim, Anam Basharat, Ramchandani Santosh, Syed F. Mehdi, Zanali Razvi, Sun K. Yoo, Barbara Lowell, Amrat Kumar, Wunnie Brima, Ann Danoff, Rachel Dankner, Michael Bergman, Valentin A. Pavlov, Huan Yang, Jesse Roth. Reuniting overnutrition and undernutrition, macronutrients, and micronutrients. Diabetes/Metabolism Research and Reviews 2019; 35(1) doi: 10.1002/dmrr.3072
|
74 |
Jeremy T. Keane, Harendran Elangovan, Rebecca A. Stokes, Jenny E. Gunton. Vitamin D and the Liver—Correlation or Cause?. Nutrients 2018; 10(4): 496 doi: 10.3390/nu10040496
|
75 |
John F. Arboleda, Geysson J. Fernandez, Silvio Urcuqui-Inchima. Vitamin D-mediated attenuation of miR-155 in human macrophages infected with dengue virus: Implications for the cytokine response. Infection, Genetics and Evolution 2019; 69: 12 doi: 10.1016/j.meegid.2018.12.033
|
76 |
Jean-Claude Souberbielle. Actualités sur la vitamine D. Cahiers de Nutrition et de Diététique 2013; 48(2): 63 doi: 10.1016/j.cnd.2013.01.001
|
77 |
Omar A Masri, Jean M Chalhoub, Ala I Sharara. Role of vitamins in gastrointestinal diseases. World Journal of Gastroenterology 2015; 21(17): 5191-5209 doi: 10.3748/wjg.v21.i17.5191
|
78 |
Asako Murayama, Takanobu Kato. Hormones, Regulators and Viruses. Vitamins and Hormones 2021; 117: 227 doi: 10.1016/bs.vh.2021.06.006
|
79 |
A. K. Obidul Huq, Ielias Uddin, Md. Tazul Islam, Eyad Ahmed, Mohammad Abu Bakr Siddique, A.N.M. Bazlur Rahim, Mesbah Uddin Talukder, Shireen Nigar, Nusrat Abedin, Mahjabeen Arjoo. COVID-19 Pandemic and Immune Boost Up: The Synergistic Role of Nutrients. Current Research in Nutrition and Food Science Journal 2021; 9(3): 755 doi: 10.12944/CRNFSJ.9.3.04
|
80 |
Ashrafali Mohamed Ismail, Prasanna Samuel, Jeyamani Ramachandran, Chundamannil Eapen Eapen, Rajesh Kannangai, Priya Abraham. Lamivudine Monotherapy in Chronic Hepatitis B Patients from the Indian Subcontinent: Antiviral Resistance Mutations and Predictive Factors of Treatment Response. Molecular Diagnosis & Therapy 2014; 18(1): 63 doi: 10.1007/s40291-013-0054-3
|
81 |
Vandana Kalia, Surojit Sarkar. Feldman and Pike's Vitamin D. 2024; : 1011 doi: 10.1016/B978-0-323-91338-6.00045-8
|
82 |
Ivan Gentile, Antonio Riccardo Buonomo, Guglielmo Borgia. Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection. Expert Review of Anti-infective Therapy 2014; 12(9): 1033 doi: 10.1586/14787210.2014.940898
|
83 |
Matthew T. Kitson, Christoph Sarrazin, Pierluigi Toniutto, Guy D. Eslick, Stuart K. Roberts. Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: A systematic review and meta-analysis. Journal of Hepatology 2014; 61(6): 1247 doi: 10.1016/j.jhep.2014.08.004
|
84 |
Livia Salmi, Matteo Nazzareno Barbaglia, Carlo Smirne, Sara Bianco, Giulia Guaschino, Maria Grazia Stella Crobu, Rosalba Minisini, Mario Pirisi. Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis. The Open Rheumatology Journal 2018; 12(1): 279 doi: 10.2174/1874312901812010279
|
85 |
Maheen Siddiqui, Judhell S. Manansala, Hana A. Abdulrahman, Gheyath K. Nasrallah, Maria K. Smatti, Nadin Younes, Asmaa A. Althani, Hadi M. Yassine. Immune Modulatory Effects of Vitamin D on Viral Infections. Nutrients 2020; 12(9): 2879 doi: 10.3390/nu12092879
|
86 |
Kristine R Broglio, Eric S Daar, Melanie Quintana, Yong Yuan, Anupama Kalsekar, Brad Spellberg, Roger J Lewis, Dane van den Akker, Michelle A Detry, Trong Le, Scott M Berry. A meta-analysis platform methodology for determining the comparative effectiveness of antihepatitis C virus regimens. Journal of Comparative Effectiveness Research 2015; 4(2): 101 doi: 10.2217/cer.14.69
|
87 |
Kanika Khanna, Sukhmeen Kaur Kohli, Ravdeep Kaur, Abhay Bhardwaj, Vinay Bhardwaj, Puja Ohri, Anket Sharma, Ajaz Ahmad, Renu Bhardwaj, Parvaiz Ahmad. Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle. Phytomedicine 2021; 85: 153361 doi: 10.1016/j.phymed.2020.153361
|
88 |
Matthew T. Kitson, Peter Button, Stuart K. Roberts. Reply to: “Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection”. Journal of Hepatology 2013; 59(1): 194 doi: 10.1016/j.jhep.2013.03.001
|
89 |
Neta Gotlieb, Irena Tachlytski, Yelena Lapidot, Maya Sultan, Michal Safran, Ziv Ben-Ari. Hepatitis B virus downregulates vitamin D receptor levels in hepatoma cell lines, thereby preventing vitamin D-dependent inhibition of viral transcription and production. Molecular Medicine 2018; 24(1) doi: 10.1186/s10020-018-0055-0
|
90 |
The role of UV radiation and vitamin D in the seasonality and outcomes of infectious disease. Photochemical & Photobiological Sciences 2017; 16(3): 314 doi: 10.1039/c6pp00355a
|
91 |
Ivan Gentile, Antonio Riccardo Buonomo, Federico Borgia, Emanuela Zappulo, Giuseppe Castaldo, Guglielmo Borgia. MK-5172: a second-generation protease inhibitor for the treatment of hepatitis C virus infection. Expert Opinion on Investigational Drugs 2014; 23(5): 719 doi: 10.1517/13543784.2014.902049
|
92 |
Wanvisa Udomsinprasert, Jiraphun Jittikoon, Sorraya Sukkho, Nicha Pojarassangkul, Sermsiri Sangroongruangsri, Usa Chaikledkaew. Decreased circulating vitamin D reflects adverse outcomes of hepatitis C virus infection: A systematic review and meta-analysis. Journal of Infection 2020; 81(4): 585 doi: 10.1016/j.jinf.2020.06.025
|
93 |
Andrea D Branch, Minhee Kang, Kimberly Hollabaugh, Christina M Wyatt, Raymond T Chung, Marshall J Glesby. In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use. The American Journal of Clinical Nutrition 2013; 98(2): 423 doi: 10.3945/ajcn.112.048785
|
94 |
Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, Guglielmo Borgia. Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?. Expert Review of Anti-infective Therapy 2014; 12(7): 763 doi: 10.1586/14787210.2014.929497
|
95 |
Sunil Gupta, Scott A. Read, Nicholas A. Shackel, Lionel Hebbard, Jacob George, Golo Ahlenstiel. The Role of Micronutrients in the Infection and Subsequent Response to Hepatitis C Virus. Cells 2019; 8(6): 603 doi: 10.3390/cells8060603
|
96 |
P. O. Lang, N. Samaras, D. Samaras, R. Aspinall. How important is vitamin D in preventing infections?. Osteoporosis International 2013; 24(5): 1537 doi: 10.1007/s00198-012-2204-6
|
97 |
Ranil Jayawardena, Piumika Sooriyaarachchi, Michail Chourdakis, Chandima Jeewandara, Priyanga Ranasinghe. Enhancing immunity in viral infections, with special emphasis on COVID-19: A review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2020; 14(4): 367 doi: 10.1016/j.dsx.2020.04.015
|
98 |
Elzbieta Karczmarewicz, Edyta Czekuc-Kryskiewicz, Paweł Płudowski. Effect of vitamin D status on pharmacological treatment efficiency. Dermato-Endocrinology 2013; 5(2): 299 doi: 10.4161/derm.25279
|
99 |
Christian Wejse, Cecilie Blenstrup Patsche. Extraskeletal Effects of Vitamin D. Contemporary Endocrinology 2018; : 57 doi: 10.1007/978-3-319-73742-3_3
|
100 |
Harendran Elangovan, Sarinder Chahal, Jenny E. Gunton. Vitamin D in liver disease: Current evidence and potential directions. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017; 1863(4): 907 doi: 10.1016/j.bbadis.2017.01.001
|
101 |
Jae Yoon Jeong, Dae Won Jun, Sol Ji Park, Joo Hyun Sohn, Sang Gyune Kim, Se Whan Lee, Soung Won Jeong, Moon Young Kim, Won Kim, Jae-Jun Shim, Hyoung Su Kim, Ki Tae Suk, Sang Bong Ahn. Effects of vitamin D supplements in patients with chronic hepatitis C: a randomized, multi-center, open label study. The Korean Journal of Internal Medicine 2020; 35(5): 1074 doi: 10.3904/kjim.2018.273
|
102 |
Stephen Malnick, Yaakov Maor, Ehud Melzer, Sari Tal. Chronic Hepatitis C in the Aged: Much Ado About Nothing or Nothing to Do?. Drugs & Aging 2014; 31(5): 339 doi: 10.1007/s40266-014-0170-8
|
103 |
Л.Р. Шостакович-Корецкая, М.А. Николайчук, И.В. Будаева, О.П. Шевченко-Макаренко, В.Д. Ткаченко. Relationship between Vitamin D and Genotype, Fibrosis, Viral Load in Patients with Chronic Hepatitis C. Клиническая инфектология и паразитология 2020; (1): 71 doi: 10.34883/PI.2020.9.1.006
|
104 |
Silas D.E., Bugaje I.M., Suleman U., Mohammmad S.M., Aliyu B.. Potential Therapeutic Option used for the Cure of Covid-19 using Locally Available Indigenous Herbs (Nigeria) Containing Antioxidant, Vitamins, Minerals; thus, this will help to tackle Current Status, Challenges as well as Futuristic Perspective Globally. African Journal of Biology and Medical Research 2021; 4(4): 53 doi: 10.52589/AJBMR-AFSI6CXU
|